AMPLIFICATION OF CLINICAL EFFICACY
"Great pharmaceuticals arise through listening to ALL stakeholders"
OUR INNOVATIVE TECHNOLOGY
There is a clear unmet medical need in Rheumatoid Arthritis today with available drugs failing to successfully treat many of the patients to disease remission
At Amplio Pharma AB, our comprehensive technological solutions help individuals achieve greater health.
For Methotrexate Forte (AMP101), we use our proprietary modified retention technology, to amplify the clinical effect of low dose Methotrexate, the no 1 treatment in Rheumatoid Arthritis.
For more information, contact us today.
Our Leadership Team:
With our innovative and insightful technology, we strive to enhance patients’ every day quality of life.
Founded in 2020. Get in touch to learn more.